BIOMARIN PHARMACEUTICAL INC BMRN on Nasdaq
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001048477
0001048477
EIN:
68-0397820
68-0397820
LEI:
(CF Office: 03 Life Sciences)
Business address:
105 DIGITAL DRIVE, NOVATO, CA, 94949
Phone: 4155066700
105 DIGITAL DRIVE, NOVATO, CA, 94949
Phone: 4155066700
Mailing address:
105 DIGITAL DRIVE, NOVATO, CA, 94949
105 DIGITAL DRIVE, NOVATO, CA, 94949
Category:
Large accelerated filer
Large accelerated filer
Filings:
2,620 EDGAR filings since May 4, 1999
2,620 EDGAR filings since May 4, 1999
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- April 8, 2025 - ARS: Annual Report to Security Holders Open documentClick to Open document FilingOpen filingClick to Open filing
- April 8, 2025 - DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material Open documentClick to Open document FilingOpen filingClick to Open filing
- April 8, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- March 19, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 6, 2025 - 144: Report of proposed sale of securities Open documentClick to Open document FilingOpen filingClick to Open filing
Selected Filings
[+] 8-K (current reports)
- March 3, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 3.03 - Material Modification to Rights of Security Holders
- 5.03 - Amendments to Articles of Incorporation or Bylaws Change in Fiscal Year
- 9.01 - Financial Statements and Exhibits
- February 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.02 - Departure of Directors or Certain Officers Election of Directors Appointment of Certain Officers Compensatory Arrangements of Certain Officers
- February 19, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 24, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- October 31, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 5, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- April 26, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- April 8, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
- March 20, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- March 18, 2025 - 4: Statement of changes in beneficial ownership of securities Open documentClick to Open document FilingOpen filingClick to Open filing
- Beneficial ownership (Schedule 13D and 13G)
- February 13, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- September 30, 2024 - SC 13G: Statement of acquisition of beneficial ownership by individuals Open documentClick to Open document FilingOpen filingClick to Open filing
- July 10, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 25 of 1,004 entries
Data source:
CIK0001048477.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
